Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924612 · ClinicalTrials.gov registry record · Phase 2
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
A Phase 2 study, sponsored by Clarus Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00924612 is a Phase 2 study that has completed, run by Clarus Therapeutics. The registered enrollment target is 16 participants.
The verdict
NCT00924612, a Phase 2 study, has completed, sponsored by Clarus Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effect of food with various amounts of fat on the absorption of an oral testosterone undecanoate formulation.
Interventions
- DRUG Oral testosterone undecanoate (containing 300 mg T)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00924612
The ClinicalTrials.gov registry entry for NCT00924612 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clarus Therapeutics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral testosterone undecanoate (containing 300 mg T) is the first listed.
NCT00924612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00924612 about?
NCT00924612 is a clinical study titled "Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation". The purpose of the study is to determine the effect of food with various amounts of fat on the absorption of an oral testosterone undecanoate formulation.
What is the current status of trial NCT00924612?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2009-07. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00924612?
The interventions under investigation include: Oral testosterone undecanoate (containing 300 mg T) (DRUG).
Who is sponsoring clinical trial NCT00924612?
This trial is sponsored by Clarus Therapeutics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.